LXEO Operating Cash Flow (Statement)
Lexeo Therapeutics Inc · Operating Cash Flow (Statement)
LXEO Operating Cash Flow (Statement)
Latest reported-$88.37Mperiod ending
LXEO TTM Cash from Operations (-$54.56M → -$88.37M)
TTM operating cash flow (statement)
High-resolution chart · PNG
LXEO operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -88,367,000 | |
| -97,989,000 | |
| -98,561,000 | |
| -106,808,000 | |
| -95,067,000 | |
| -88,000,000 | |
| -81,151,000 | |
| -66,806,000 | |
| -62,949,000 | |
| -55,987,731 | |
| -59,494,731 | |
| -62,139,731 | |
| -59,979,731 | |
| -57,839,205 | |
| -54,560,000 |